BioRem Inc. (TSXV:BRM)

BioRem Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.19	11.5	5.21	2.29	3.78	4.47
Cash & Short-Term Investments	7.19	11.5	5.21	2.29	3.78	4.47
Cash Growth	-6.11%	120.70%	127.46%	-39.29%	-15.57%	-49.59%
Accounts Receivable	19.14	15.2	14.87	14.11	12.24	10.13
Receivables	19.14	15.2	14.87	14.11	12.24	10.13
Inventory	2.13	1.37	2.9	0.9	0.89	0.9
Prepaid Expenses	4.64	0.92	1.07	1.04	0.53	0.17
Other Current Assets	-	1.56	0.47	1.29	0.34	0.49
Total Current Assets	33.1	30.55	24.52	19.63	17.77	16.17
Property, Plant & Equipment	1.98	1.83	2.02	1.99	1.02	1.15
Long-Term Accounts Receivable	0.03	0.68	0.81	0.97	-	-
Long-Term Deferred Tax Assets	0.53	0.52	1.16	1.48	1.94	1.86
Total Assets	35.64	33.58	28.51	24.08	20.73	19.17

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.6	7.95	4.02	6.14	4.71	5.07
Accrued Expenses	1.88	1.84	2.44	2.13	2.66	2.51
Short-Term Debt	-	-	-	-	0.78	1.01
Current Portion of Long-Term Debt	0.61	0.59	0.57	0.55	0.53	0.5
Current Portion of Leases	0.09	0.08	0.12	0.18	0.16	0.19
Current Income Taxes Payable	0.5	0.86	0.96	0.17	0.89	0.45
Current Unearned Revenue	6.94	4.59	6.37	4.31	2.57	3.02
Other Current Liabilities	0.65	0.58	0.54	0.43	0.62	0.49
Total Current Liabilities	16.26	16.49	15.02	13.89	12.92	13.23
Long-Term Debt	0.96	1.26	1.86	2.43	2.98	3.5
Long-Term Leases	0.84	0.89	1.01	1.03	0.31	0.47
Total Liabilities	18.06	18.65	17.89	17.36	16.21	17.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.28	5.2	5.2	5	4.91	4.91
Additional Paid-In Capital	2.54	2.53	2.47	2.37	2.26	2.17
Retained Earnings	8.01	5.86	1.13	-1.92	-4.1	-5.71
Comprehensive Income & Other	1.76	1.34	1.83	1.27	1.45	0.6
Shareholders' Equity	17.59	14.93	10.63	6.72	4.52	1.96
Total Liabilities & Equity	35.64	33.58	28.51	24.08	20.73	19.17

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.49	2.83	3.56	4.19	4.75	5.67
Net Cash (Debt)	4.69	8.67	1.66	-1.89	-0.97	-1.19
Net Cash Growth	3.98%	423.68%	-	-	-	-
Net Cash Per Share	0.25	0.47	0.09	-0.12	-0.06	-0.03
Filing Date Shares Outstanding	16.12	16.13	15.7	15.7	15.5	15.48
Total Common Shares Outstanding	16.12	16.13	15.7	15.7	15.5	15.48
Working Capital	16.84	14.05	9.51	5.74	4.85	2.93
Book Value Per Share	1.09	0.93	0.68	0.43	0.29	0.13
Tangible Book Value	17.59	14.93	10.63	6.72	4.52	1.96
Tangible Book Value Per Share	1.09	0.93	0.68	0.43	0.29	0.13
Machinery	-	3.01	2.72	2.58	2.71	2.47
Leasehold Improvements	-	0.88	0.89	0.88	0.9	0.89
Order Backlog	-	65.3	56.1	50.1	38	24.93

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error